Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 4 46-4, 1999, Pages

  Wennberg, Paul W ^a   Miller, Virginia M ^a   Rabelink, Ton ^b   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

C type natriuretic peptide; Guanosine 3',5' cyclic monophosphate

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HS 142 1; INDOMETACIN; N(G) METHYLARGININE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CORONARY ARTERY; DOG; ENDOTHELIUM CELL; ENZYME ACTIVATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0032744495     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.4.h1618     Document Type: Article

References (21)

1. Amin, J., O. A. Carretero, and S. Ito. Mechanism of action of atrial natriuretic factor and C-type natriuretic peptide. Hypertension 27: 684-687, 1996.
2. Banks, M., C. Wei, C. H. Kim, J. C. Burnett, Jr., and V. M. Miller. Mechanism of relaxations to C-type natriuretic peptide in veins. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1907-H1911, 1996.
3. Barton, M., J. L. Beny, L. V. d'Uscio, T. Wyss, G. Noll, and T. F. Luscher. Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries. J. Cardiovasc. Pharmacol. 31: 377-383, 1998.
4. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
5. Eckman, D. M., J. S. Weinert, I. L. O. Buxton, and K. D. Keef. Cyclic GMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery. Br. J. Pharmacol. 111: 1053-1060, 1994.
6. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
7. Hutchinson, P. J., R. M. J. Palmer, and S. Moncada. Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur. J. Pharmacol. 141: 445-451, 1987.
8. Kilpatrick, E. V., and T. M. Cocks. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br. J. Pharmacol. 112: 557-565, 1994.
9. Koller, K. J., F. J. DeSauvage, D. G. Lowe, and D. V. Goeddel. Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell Biol. 12: 2581-2590, 1992.
10. Koller, K. J., D. G. Lowe, G. L. Bennett, N. Minamino, K. Kangawa, H. Matsuo, and D. V. Goeddel. Selective activation of the B type natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120-123, 1991.
11. + channels in cultured vascular smooth muscle cells. Circ. Res. 74: 471-476, 1994.
12. Lweko, B., U. Wendt, M. Szczepanska-Konkel, J. Stepinski, K. Drewnoska, and S. Angielski. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli. Kidney Int. 52: 654-659, 1997.
13. Nakashima, M., J. Mombouli, A. A. Taylor, and P. M. Vanhoutte. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J. Clin. Invest. 92: 2867-2871, 1993.
14. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
15. Rees, D. D., R. M. J. Palmer, H. F. Hodson, and S. Moncada. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96: 418-424, 1989.
16. Souga, S., K. Nakao, H. Itoh, Y. Kamatsu, Y. Ogawa, H. Hama, and H. Imura. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. J. Clin. Invest. 90: 1145-1149, 1992.
17. Stingo, A. J., A. L. Clavell, D. M. Heublein, C.-M. Wei, M. R. Pittelkow, and J. C. Burnett, Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1318-H1321, 1992.
18. Swierkosz, T. A., J. A. Mitchell, T. D. Warner, R. M. Botting, and J. R. Vane. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostaglandin H synthase. Br. J. Pharmacol. 114: 1335-1342, 1995.
19. Wei, C., L. L. Aarhus, V. M. Miller, and J. C. Burnett, Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H71-H73, 1993.
20. Wei, C., S. Hu, V. M. Miller, and J. C. Burnett, Jr. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 205: 765-771, 1994.
21. Zhang, P. L., W. Jimenez, H. S. Mackenzie, J. Guo, J. L. Troy, J. Ros, P. Angelli, V. Arroyo, and B. M. Brenner. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo. J. Am. Soc. Nephrol. 5: 1099-1105, 1994.